The Food and Drug Administration on Saturday issued an emergency use authorization to Regeneron for its covid-19 monoclonal antibody cocktail, which is made up of the antibodies casirivimab and imdevimab, citing a reduction in hospitalizations and emergency r…read more
Read more...
See Also : #Health_Offers
Source : eMartmarket
Comments
Post a Comment